Clinical Trial Update: MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104) [Phase 3]

View source ↗

Summary

Phase III trial evaluating MK0431/ONO-5435 as an add-on to voglibose in patients with type 2 diabetes mellitus; study completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK0431/ONO-5435 (ONO-5435)
• Voglibose (voglibose)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 3 | Status: COMPLETED | Results posted: 2011-09-13